Factory Setup and GMP Readiness Workbook

Dosage forms, products, markets, licence categories and intended inspection standards are approved before design is fixed.

Scope, objectives, governance forums, accountable sponsor, Quality authority and escalation routes are defined.

Home-country, export-market, product, pharmacopoeial, environmental and licence requirements are version-controlled and assigned.

Design, procurement, construction and start-up records use approved review, change, deviation and configuration controls.

Engineering, regulatory, Quality, laboratory, supply, people and validation dependencies share one controlled plan.

Capital, validation, spares, calibration, utilities, laboratory, staffing, working capital and start-up loss are funded.

Contract design, construction, testing, calibration, warehousing or manufacturing activities have qualified providers and retained site oversight.

Land use, construction, utilities, environmental, fire, occupational and manufacturing approvals are sequenced and tracked.

Critical quality, stability, packaging, storage, shelf-life and market requirements are defined for the initial portfolio.

Sensitising, highly potent, hormonal, cytotoxic, biological, sterile and other special products are identified before site zoning.

Unit operations, material transformations, CQAs, CPPs, IPCs, losses, holds and data flows are mapped.

Demand ranges, batch sizes, line rates, yields, changeovers, utilization, maintenance and expansion are reconciled.

Proposed formulae, process, equipment, batch size, methods, specifications, pack and site match regulatory commitments.

Development history, risks, master formulae, analytical methods, stability, validation and deviations are complete enough to transfer.

Worst cases, residues, campaign lengths, dirty/clean holds, bulk holds and sampling feasibility inform facility and equipment design.

Risks are linked to design controls, qualification, control strategy, procedures and continued verification.

Location addresses flooding, access, neighbours, dust, pests, security, water, power, waste, labour and future expansion.

Production, laboratory, warehouse, utilities, waste, administration and expansion zones support controlled operations.

Flows avoid mix-up, contamination, unsafe crossing and uncontrolled access under normal and abnormal conditions.

Every GMP room has intended use, occupancy, finishes, utilities, pressure, temperature, humidity, cleaning and equipment loads.

Surfaces, junctions, penetrations, ceilings, drains and concealed spaces are durable, accessible and appropriate to contamination risk.

Gowning stages, toilets, washing, rest, maintenance and cleaning stores prevent direct impact on GMP areas.

Receipt, de-dusting, sampling, quarantine, released, rejected, returned, cold-chain and dispatch areas maintain status and traceability.

Final layouts, utility schematics, P&IDs, room numbers, materials and fire systems reflect installed reality and approved changes.

Room cleanliness, pressure, temperature, humidity, recovery, occupancy and operating states are justified by product and process risk.

Airflow, segregation, source capture and cleaning controls address dust, microorganisms, sensitizers and potent compounds.

Air-handling boundaries and recirculation decisions prevent cross-contamination and unsafe discharge.

Peak heat, moisture, people, equipment, leakage, seasonal climate and degraded modes are covered with appropriate margins.

Filter grades, terminal arrangements, integrity needs, access, safe-change and differential monitoring match risk.

Critical pressures, temperatures, humidity and particulate/microbial conditions have alert, action, escalation and data-retention logic.

Balancing, airflow, HEPA integrity, pressure, recovery, temperature, humidity and classification tests are risk-based and pre-approved.

Set points, operating states, cleaning, filter changes, requalification, trends and response to failures are controlled.

Peak, average, future and emergency demands are defined with required quality at each point of use.

Source variability, pretreatment, generation technology, sanitisation and reject handling support the required water grade.

Hygienic materials, slopes, velocity, temperature or chemical control, sampling and drainability limit biofilm and stagnation.

Direct and indirect product-contact utilities have defined purity, capacity, monitoring and contamination controls.

Power quality, redundancy, generator/UPS coverage, safe shutdown and fuel availability protect critical processes, data and materials.

Oil, water, particles, microorganisms and pressure at use points are specified according to product contact and risk.

Critical parameters, sampling, alert/action limits, trends, alarms and product-impact assessment are defined before GMP use.

Turnover, commissioning, IQ/OQ/PQ, preventive maintenance, calibration and requalification show continued control.

Every GMP asset has a unique ID, intended use, capacity, location, product contact and lifecycle criticality.

Capacity, materials, cleanability, containment, controls, data, alarms, change parts and acceptance criteria are explicit.

Vendor capability, software, documentation, fabrication quality and agreed challenge tests are verified before shipment and acceptance.

Recipes, access, audit trails, alarms, interfaces, time, backup and electronic records are specified with the equipment.

Maintainable access, calibrated ranges, standards, preventive tasks, lubricants, critical spares and technical support are available.

Product-contact parts, dismantling, dead legs, surfaces, cleaning methods and verification sampling are practical and safe.

Machine guarding, exposure control, interlocks, lifting, access and operator tasks are assessed without undermining GMP controls.

Drawings, certificates, manuals, parts, software, calibration, commissioning, punch closure and qualification status are complete.

Rooms, equipment, utilities, materials, documents, status labels and cleaning controls are released before trial or GMP manufacture.

Approved instructions match the validated process, installed equipment, registered details, data needs and actual sequence.

Identity, weighing, verification, dust control, labels, segregation, reconciliation and material return are demonstrated.

Methods, locations, frequency, limits, instruments, sample handling, actions and data review are ready at the point of use.

Theoretical and actual quantities, acceptable ranges, scrap, samples, printed components and discrepancy escalation are controlled.

Approved components, line clearance, coding, online verification, specimens, vision systems and destruction prevent mix-ups.

Equipment status, area cleaning, dirty/clean holds, bulk holds, campaign duration and expiry of prepared items are visible and justified.

Initial campaigns have enhanced oversight, issue escalation, daily review, defined stop criteria and management visibility.

Risk tiers, manufacturer identity, due diligence, audits, samples, change notification and periodic performance are defined.

Starting, packaging and consumable requirements cover identity, compendial/functional tests, storage, retest and supplier controls.

Physical and electronic status agree for quarantine, released, rejected, returned, recalled, expired and controlled materials.

All controlled rooms, cold rooms and chambers are mapped through seasonal or justified worst-case conditions with alarms.

Lot, status, location, quantity, retest/expiry, transaction history and reconciliation remain accurate from receipt to disposition.

Cold-chain, flammable, toxic, controlled-drug, printed and high-value materials have authorised access and specific safeguards.

Qualified routes, providers, packaging, temperature monitoring, security, delivery evidence and excursion handling protect product.

Critical materials, single sources, lead times, foreign exchange, import permits, safety stocks and alternates are actively controlled.

Chemical, instrumental, microbiology, sample, reagent, standard, wash and archive needs fit the product portfolio and release volume.

URS, qualification, calibration, maintenance, software, access, consumables and backup instruments support intended methods.

Current methods and specifications match registered requirements and are validated, verified or transferred before release testing.

Qualification, traceability, preparation, standardisation, growth promotion, storage, labelling and expiry are operational.

Worksheets, notebooks, calculations, chromatographic processing, second-person review and approval preserve complete raw data.

Laboratory assessment, hypotheses, retest/resample limits, manufacturing review, impact and CAPA follow approved governance.

Protocols, bracketing/matrixing, conditions, alarms, backup, pulls, tests, trends and excursion decisions meet commitments.

Water, environment, bioburden, microbial limits, preservative or sterility activities are resourced and controlled as applicable.

Equipment software, BMS, EMS, ERP, LIMS, CDS, eQMS, spreadsheets and interfaces are identified with owners and critical data.

Lifecycle deliverables, supplier leverage, risk testing, configuration, release and periodic review are defined by criticality.

Unique identities, roles, privileged access, time synchronisation, audit trails and critical-event review support attribution.

Transfers, conversions, recipes, specifications and master data have controlled creation, verification, reconciliation and approval.

Frequency, segregation, encryption, retention, restore tests, recovery objectives and degraded operation are proven.

Provider competence, hosting, security, service, incident, data ownership, audit, subcontracting and exit are assessed.

User management, incident, change, audit trail, backup, business continuity and system review procedures are effective before use.

Requirements, tests, deviations, traceability, data migration, security and residual risks support formal use authorization.

Senior management defines the PQS, Quality authority, escalation and independent batch-disposition responsibility.

Policies, SOPs, forms, masters, electronic records, issuance, revision, archive, retention and destruction share one controlled lifecycle.

Risk decisions, unplanned events, root cause, actions, extensions, effectiveness and changes are controlled and linked.

Laboratory and market signals are triaged, investigated, escalated, trended and capable of effective market action.

Risk-based audit, product review, quality metrics and management oversight detect recurring and systemic weaknesses.

Critical data, ownership, ALCOA+, paper/electronic controls, review, culture, reporting channels and remediation are established.

Executed records, deviations, OOS, IPCs, yields, validation, status and market requirements support documented disposition.

The site description, licences, layouts, products, utilities, QMS and outsourced operations agree with current evidence.

Headcount, shifts, supervision, independent Quality/QC, engineering, validation, regulatory and support functions match the operating plan.

Responsibilities, qualifications, GMP authority, conflicts, delegation and deputies are approved before personnel act independently.

Each role maps to GMP, procedure, safety, equipment, task and requalification requirements.

Critical roles have documented education, experience, assessment, practical demonstration and authorised scope.

Medical fitness, illness reporting, personal hygiene, gown selection, laundering and gowning qualification match area risk.

Temporary personnel, technical specialists and visitors are qualified, inducted, supervised and access-limited.

Approved materials, qualified trainers, attendance, competence, retraining, overdue escalation and data integrity are operational.

Every shift has adequate trained operators, reviewers, maintenance response, laboratory support, deputies and escalation coverage.

Facilities, utilities, equipment, methods, cleaning, processes, systems and transport have risk-based lifecycle strategies.

URS and risk controls are traced through design; suitable commissioning evidence is planned, reviewed and retained for qualification use.

Pre-approved tests challenge installation, operation, alarms, ranges, loads, users and worst cases with controlled deviations.

Process knowledge, scale-up, sampling, acceptance, batches, statistics and deviations demonstrate reproducibility and control.

Worst-case products/equipment, limits, methods, recovery, locations, holds, campaigns and routine verification are scientifically justified.

Methods are suitable at the receiving laboratory and support raw materials, IPCs, release, cleaning and stability decisions.

Process holds, cleaned-equipment holds, mapped storage and shipping conditions are supported before routine use.

Critical parameters, utilities, process capability, cleaning, alarms, trends and change signals drive periodic review and requalification.

Environmental assessment, emissions, effluent, waste, water abstraction, hazardous storage and operating permits cover the final design.

Hazards, compatibility, storage, transfer, exposure, spill, disposal and emergency controls are built into the process.

Detection, alarm, suppression, evacuation, emergency power, access and response reflect chemical, occupancy and business risks.

Exposure limits, containment, local extraction, PPE, monitoring, health surveillance and manual handling are risk-based.

Segregation, treatment, contractor qualification, reconciliation and environmental monitoring address product and API hazards.

Site perimeter, sensitive areas, controlled substances, data rooms, printed components and dispatch have authorised and reviewable access.

Power, water, IT, cold storage, utilities, critical suppliers, laboratory, fire and natural hazards have tested recovery strategies.

Fire, spill, medical, utility, data, security and recall exercises produce actions that enter the PQS and management review.